SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Parenteral Drugs (India) informs about CIRP updates

23 Feb 2023 Evaluate
Parenteral Drugs (India) has informed that the National Company Law Tribunal, Mumbai has ordered the commencement of Corporate Insolvency Resolution Process of Parenteral Drugs (India) vide order, CP IB 690/MB/2020 u/s 7 of IBC dated 09/02/2023 (Thursday), Certified True Copy obtained on 10/02/2023, Friday late evening, thus CIRP Initiated by IRP from 11/02/2023.

The above information is a part of company’s filings submitted to BSE.

Parenteral Drugs Share Price

3.39 0.00 (0.00%)
21-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×